KMPHARMACEUTICAL Co.,Ltd. (KOSDAQ:225430)
South Korea · Delayed Price · Currency is KRW 698.00
+16.00 (2.35%)
At close: Sep 14, 2026
KMPHARMACEUTICAL Market Cap
KMPHARMACEUTICAL has a market cap or net worth of 3.89 billion as of October 8, 2026. It is the 46,943rd most valuable company in the world and the 2,720th biggest in South Korea. Its market cap has decreased by 78.52% in one year.
Market Cap
3.89B
Enterprise Value
22.42B
Revenue
16.98B
Global Rank
Country Rank
#2,720 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since September 13, 2018, KMPHARMACEUTICAL's market cap has decreased from 29.16B to 3.89B, a decrease of -86.65%. That is a compound annual growth rate of -22.23%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 14, 2026 | 3.89B | -74.05% |
| Dec 30, 2025 | 15.00B | -21.46% |
| Dec 30, 2024 | 19.10B | -29.96% |
| Dec 28, 2023 | 27.27B | -38.49% |
| Dec 29, 2022 | 44.34B | -28.54% |
| Dec 30, 2021 | 62.05B | -0.47% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Sep 13, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| TS Trillion | 28.91B |
| KODI CO., LTD | 26.94B |
| Csa Cosmic | 24.38B |
| INSAN | 21.00B |
| SR biotek | 19.96B |
| Nord Mason | 19.41B |
| Outin Futures | 18.82B |
| INNOGENE | 18.74B |